Ibritumomab and Zohydro ER Capsules
Determining the interaction of Ibritumomab and Zohydro ER Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab Tiuxetan
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab-Zoladex
- Ibritumomab-Zoladex (Goserelin Implant 10.8 mg)
- Ibritumomab-Zoladex (Goserelin Implant 3.6 mg)
- Ibritumomab-Zoladex 3-Month
- Ibritumomab-Zoladex Implant
- Ibritumomab-Zolate
- Zohydro ER Capsules-Ibritumomab Intravenous
- Zohydro ER Capsules-Ibritumomab Tiuxetan
- Zohydro ER Capsules-Ibrutinib
- Zohydro ER Capsules-Ibrutinib Capsules
- Zohydro ER Capsules-Ibrutinib Tablets
- Zohydro ER Capsules-Ibu